This year is shaping up to be a big one for Restek. In January, the company, which has provided chromatography columns and accessories since 1985, became 100% employee owned. Restek now runs under an employee stock ownership program. In February, Restek opened its first Asian office in Tokyo, Japan. Due to the change in ownership, […]
Company Announcements Bruker opened its expanded applications and technology demonstration lab in Yokohama, Japan, in February. The lab is co-located with Bruker’s R&D and manufacturing facility for X-ray analysis systems. Bruker has close to ¥10 billion ($107 million) in revenue in Japan and almost 150 employees in the country. Scottish Enterprise reported in February that […]
On March 11, the US Omnibus Appropriations Act of 2009 became law, funding 12 federal agencies for which Congress had not passed a budget for the fiscal year that started on October 1, 2008. Since last fall, these agencies had been funded under a continuing extension (see IBO 10/15/08). According to the American Association for […]
A new report from the Centers for Disease Control and Prevention (CDC) indicates that US food safety has not improved since 2005. Sixteen of every 100,000 people had confirmed cases of salmonella in 2008, compared to 14 out of 100,000 in 2005. Although the increase may be a statistical anomaly, many foodborne illnesses, including listeria […]
In calendar year 2008, Thermo Fisher Scientific retained its position as the number one provider of analytical and life science instruments and aftermarket products, according to IBO’s annual calculation of the top 30 companies. The top 30 companies generated an estimated $26.6 billion in sales of analytical and life science instruments and aftermarket products last […]
A Brazilian pluripotent stem cell research initiative will award eight university labs with $9.3 million grants over three years to create Cell Technology Centers. One such Center, the National Laboratory for Human Embryonic Cells (LaNCE), based at the Federal University of Rio de Janeiro and the University of São Paulo will house a national stem […]
According to Alcimed, a research group based in France, as many as 20% of small biotechnology firms in Europe could go bankrupt this year. These firms need new funding within the next year and a half in order to survive. Alcimed estimates that the sector needs at least $2.6 billion in annual funding to maintain […]
Sunnyvale, CA 4/14/09—Dionex has named Dr. Frank Witney president, CEO and a member of the Board of Directors effective April 30. He replaces Dr. Lukas Braunschweiler, who announced earlier this year that he was leaving the company to take a position at Ruag Holding AG (see IBO 12/15/08). Most recently, Dr. Witney served as executive […]
Billerica, MA 4/3/09—Bruker Advanced Supercon, a subsidiary of Bruker that provides low-temperature superconducting wire and high-temperature superconductor solutions, has acquired the research instruments portion of ACCEL Instruments GmbH from Varian Medical Systems for an undisclosed amount. Varian Medical retained ACCEL’s proton therapy business. As a result of the acquisition, Bruker has created two new subsidiaries: […]
Although there have been some marginally portable near infrared (NIR) spectrometers available for a number of years, the market has recently taken off. This is due to the rise of more effective handheld NIR instruments. While the primary applications for portable and handheld NIR instruments are in the polymers and plastics industry, there is growing […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
